Biogen Shares Decline After Detailed Diranersen Alzheimer's Study DataZacks Investment Research • 07/15/26
It's been three months since Lilly launched its obesity pill. Most people are taking Novo's pill instead.WSJ • 07/15/26
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD SurgeZacks Investment Research • 07/14/26
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?The Motley Fool • 07/14/26
Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst UpgradesBenzinga • 07/13/26
Top Funds Bet Big On 19 Stocks — Including Eye-Popping Sums On These FiveInvestors Business Daily • 07/10/26
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatmentPRNewsWire • 07/09/26
Wall Street Is Betting on Eli Lilly's GLP-1 Portfolio — It's Missing the $1 Trillion Opportunity24/7 Wall Street • 07/08/26
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?Zacks Investment Research • 07/08/26